Laura Santambrogio

Laura Santambrogio

Auto-generated profile, based on publicly available information

Laura Santambrogio

Department of Radiation Oncology, Weill Cornell Medicine, New York, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Developmental Cell
Verified
Journal Article
Closed access
RSRanjit Sahu
Ranjit Sahu
SKSusmita Kaushik
Susmita Kaushik
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
ECElvira S. Cannizzo
Elvira S. Cannizzo
BSBrian Scharf
Brian Scharf
LSLaura Santambrogio
Laura Santambrogio

1 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
CLClaire Lhuillier
Claire Lhuillier
NRNils-Petter Rudqvist
Nils-Petter Rudqvist
TYTakahiro Yamazaki
Takahiro Yamazaki
TZTuo Zhang
Tuo Zhang
MCMaud Charpentier
Maud Charpentier
SDSandra Demaria
Sandra Demaria
Neoantigens generated by somatic nonsynonymous mutations are key targets of tumor-specific T cells, but only a small number of mutations predicted to be immunogenic are presented by MHC molecules on cancer cells. Vaccination studies in mice and patients have shown that the majority of neoepitopes that elicit T cell responses fail to induce significant antitumor activity, for incompletely understood reasons. We report that radiotherapy upregulates the expression of genes containing immunogenic mutations in a poorly immunogenic mouse model of triple-negative breast cancer. Vaccination with neoepitopes encoded by these genes elicited CD8+ and CD4+ T cells that, whereas ineffective in preventing tumor growth, improved the therapeutic efficacy of radiotherapy. Mechanistically, neoantigen-specific CD8+ T cells preferentially killed irradiated tumor cells. Neoantigen-specific CD4+ T cells were required for the therapeutic efficacy of vaccination and acted by producing Th1 cytokines, killing irradiated tumor cells, and promoting epitope spread. Such a cytotoxic activity relied on the ability of radiation to upregulate class II MHC molecules as well as the death receptors FAS/CD95 and DR5 on the surface of tumor cells. These results provide proof-of-principle evidence that radiotherapy works in concert with neoantigen vaccination to improve tumor control.

17 July 2014 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BSBrian Scharf
Brian Scharf
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
VZValerio Zolla
Valerio Zolla
GPGiorgio Perino
Giorgio Perino
BYBo Yan
Bo Yan
LSLaura Santambrogio
Laura Santambrogio
Occupational and environmental exposure to Co and Cr has been previously linked to a wide array of inflammatory and degenerative conditions and cancer. Recently, significant health concerns have been raised by the high levels of Cr and Co ions and corrosion products released by biomedical implants. Herein, we set to analyze the biological responses associated with Co and Cr toxicity. Histological, ultrastructural, and elemental analysis, performed on Cr and Co exposed patients reveal the presence of corrosion products, metallic wear debris and metal ions at varying concentrations. Metallic ions and corrosion products were also generated in vitro following macrophage phagocytosis of metal alloys. Ex vivo redox proteomic mapped several oxidatively damaged proteins by Cr(III) and Co(II)-induced Fenton reaction. Importantly, a positive correlation between the tissue amounts of Cr(III) and Co(II) ions and tissue oxidative damage was observed. Immobilized- Cr(III) and Co(II) affinity chromatography indicated that metal ions can also directly bind to several metallo and non-metalloproteins and, as demonstrated for aldolase and catalase, induce loss of their biological function. Altogether, our analysis reveals several biological mechanisms leading to tissue damage, necrosis, and inflammation in patients with Cr and Co-associated adverse local tissue reactions.

28 February 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
OJOk Hee Jeon
Ok Hee Jeon
DWDavid R. Wilson
David R. Wilson
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
SRSona Rathod
Sona Rathod
CCChristopher Cherry
Christopher Cherry
JEJennifer Elisseeff
Jennifer Elisseeff
Senescent cells (SnCs) are increasingly recognized as central effector cells in age-related pathologies. Extracellular vesicles (EVs) are potential cellular communication tools through which SnCs exert central effector functions in the local tissue environment. To test this hypothesis in a medical indication that could be validated clinically, we evaluated EV production from SnCs enriched from chondrocytes isolated from human arthritic cartilage. EV production increased in a dose-responsive manner as the concentration of SnCs increased. The EVs were capable of transferring senescence to nonsenescent chondrocytes and inhibited cartilage formation by non-SnCs. microRNA (miR) profiles of EVs isolated from human arthritic synovial fluid did not fully overlap with the senescent chondrocyte EV profiles. The effect of SnC clearance was tested in a murine model of posttraumatic osteoarthritis. miR and protein profiles changed after senolytic treatment but varied depending on age. In young animals, senolytic treatment altered expression of miR-34a, -30c, -125a, -24, -92a, -150, and -186, and this expression correlated with cartilage production. The primary changes in EV contents in aged mice after senolytic treatment, which only reduced pain and degeneration, were immune related. In sum, EV contents found in synovial fluid may serve as a diagnostic for arthritic disease and indicator for therapeutic efficacy of senolytic treatment.

15 May 2015 in Aging Cell
Verified
Journal Article
Open access
PDF file
VZValerio Zolla
Valerio Zolla
INIrina Tsoy Nizamutdinova
Irina Tsoy Nizamutdinova
BSBrian Scharf
Brian Scharf
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
DMDaisuke Maejima
Daisuke Maejima
LSLaura Santambrogio
Laura Santambrogio
The role of lymphatic vessels is to transport fluid, soluble molecules, and immune cells to the draining lymph nodes. Here, we analyze how the aging process affects the functionality of the lymphatic collectors and the dynamics of lymph flow. Ultrastructural, biochemical, and proteomic analysis indicates a loss of matrix proteins, and smooth muscle cells in aged collectors resulting in a decrease in contraction frequency, systolic lymph flow velocity, and pumping activity, as measured in vivo in lymphatic collectors. Functionally, this impairment also translated into a reduced ability for in vivo bacterial transport as determined by time-lapse microscopy. Ultrastructural and proteomic analysis also indicates a decrease in the thickness of the endothelial cell glycocalyx and loss of gap junction proteins in aged lymph collectors. Redox proteomic analysis mapped an aging-related increase in the glycation and carboxylation of lymphatic's endothelial cell and matrix proteins. Functionally, these modifications translate into apparent hyperpermeability of the lymphatics with pathogen escaping from the collectors into the surrounding tissue and a decreased ability to control tissue fluid homeostasis. Altogether, our data provide a mechanistic analysis of how the anatomical and biochemical changes, occurring in aged lymphatic vessels, compromise lymph flow, tissue fluid homeostasis, and pathogen transport.

11 April 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MBMaria A.S. Broggi
Maria A.S. Broggi
LMLea Maillat
Lea Maillat
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
NBNatacha Bordry
Natacha Bordry
PCPatricia Corthésy
Patricia Corthésy
MSMelody A. Swartz
Melody A. Swartz
Liquid biopsies allow monitoring of cancer progression and detection of relapse, but reliable biomarkers in melanoma are lacking. Because secreted factors preferentially drain to lymphatic vessels before dilution in the blood, we hypothesized that lymph should be vastly enriched in cancer biomarkers. We characterized postoperative lymphatic exudate and plasma of metastatic melanoma patients after lymphadenectomy and found a dramatic enrichment in lymphatic exudate of tumor-derived factors and especially extracellular vesicles containing melanoma-associated proteins and miRNAs, with unique protein signatures reflecting early versus advanced metastatic spread. Furthermore, lymphatic exudate was enriched in memory T cells, including tumor-reactive CD137+ and stem cell–like types. In mice, lymph vessels were the major route of extracellular vesicle transport from tumors to the systemic circulation. We suggest that lymphatic exudate provides a rich source of tumor-derived factors for enabling the discovery of novel biomarkers that may reflect disease stage and therapeutic response. Graphical Abstract